Cargando…

Correction: The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials

Detalles Bibliográficos
Autores principales:	Rados, Dimitris Varvaki, Pinto, Lana Catani, Remonti, Luciana Reck, Leitão, Cristiane Bauermann, Gross, Jorge Luiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920361/ https://www.ncbi.nlm.nih.gov/pubmed/27340828 http://dx.doi.org/10.1371/journal.pmed.1002091

Ejemplares similares

The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials
por: Varvaki Rados, Dimitris, et al.
Publicado: (2016)

Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis
por: Pinto, Lana Catani, et al.
Publicado: (2015)

Metabolic effects of antihyperglycemic agents and mortality: meta-analysis of randomized controlled trials
por: Rados, Dimitris Varvaki, et al.
Publicado: (2020)

Thyroid Ultrasound Features and Risk of Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies
por: Remonti, Luciana Reck, et al.
Publicado: (2015)

Screening for coronary artery disease in patients with type 2 diabetes: a meta-analysis and trial sequential analysis
por: Rados, Dimitris V, et al.
Publicado: (2017)

Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis
por: Pinto, Lana C., et al.
Publicado: (2018)

Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis
por: Pinto, Lana C., et al.
Publicado: (2019)

Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis
por: Pinto, Lana C., et al.
Publicado: (2022)

Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease
por: Canani, Luís Henrique, et al.
Publicado: (2013)

Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis
por: Dellamea, Bruno Schmidt, et al.
Publicado: (2014)

Laughter as medicine: A systematic review and meta-analysis of interventional studies evaluating the impact of spontaneous laughter on cortisol levels
por: Kramer, Caroline Kaercher, et al.
Publicado: (2023)

Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study
por: Furtado de Souza, Camila, et al.
Publicado: (2012)

Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies
por: Garcia, Tiago Severo, et al.
Publicado: (2017)

Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality
por: Patel, Amit, et al.
Publicado: (2014)

Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality
Publicado: (2014)

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies
por: Rao, Ajay D., et al.
Publicado: (2008)

Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel
por: Kalra, S., et al.
Publicado: (2020)

Trial sequential analysis: plain and simple
por: De Cassai, Alessandro, et al.
Publicado: (2021)

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
por: Volke, Vallo, et al.
Publicado: (2022)

Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021)

Trial Sequential Analysis in systematic reviews with meta-analysis
por: Wetterslev, Jørn, et al.
Publicado: (2017)

Trial sequential analysis: novel approach for meta-analysis
por: Kang, Hyun
Publicado: (2021)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Correction to: Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021)

Sequential Experimentation in Clinical Trials: Design and Analysis
por: Bartroff, Jay, et al.
Publicado: (2013)

Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis
por: Dieter, Cristine, et al.
Publicado: (2022)

Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis
por: Caldeira, Daniel, et al.
Publicado: (2017)

Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials
por: Huang, Haohai, et al.
Publicado: (2016)

The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes
por: Vaccaro, Olga, et al.
Publicado: (2012)

Low Levels of Usual Physical Activity Are Associated with Higher 24 h Blood Pressure in Type 2 Diabetes Mellitus in a Cross-Sectional Study
por: Zucatti, Alessandra Teixeira Neto, et al.
Publicado: (2017)

Nitric oxide system and diabetic nephropathy
por: Dellamea, Bruno Schmidt, et al.
Publicado: (2014)

Decrease in Pancreatic Perfusion of Patients with Type 2 Diabetes Mellitus Detected by Perfusion Computed Tomography
por: Garcia, Tiago Severo, et al.
Publicado: (2021)

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
por: Srivanichakorn, Weerachai, et al.
Publicado: (2015)

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
por: Gebrie, Desye, et al.
Publicado: (2021)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Can Sulfonylureas for Agricultural Use Cause Diabetes? A Report of Three Cases
por: Kampouraki, Maria, et al.
Publicado: (2023)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
por: Komajda, Michel, et al.
Publicado: (2008)

Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis
por: Volbeda, M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iib9cg0roncm4v1sdih07aucco